FeverAI-FEVERNCT07086547
Impact of Artificial Intelligence-Supported Educational Intervention on Mothers' Fever Management
A study testing AI-Based Fever Management Education in people with Fever and Pediatric Fever Management, run by TC Erciyes University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to evaluate the effect of an artificial intelligence (AI)-based educational program on mothers' fever management practices and anxiety related to fever in children. Fever is a common symptom in pediatric patients, especially under the age of three, causing repeated health concerns for parents. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women only
- Conditions the study is for
- Fever, Pediatric Fever Management, Parental Anxiety
- What is being tested?
- AI-Based Fever Management Education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2025to 30 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Mothers aged over 18 years,
- Mothers with children aged between 6 months and 5 years,
- No hearing problems,
- Agree to participate in the study,
- Presenting to the pediatric emergency department with a complaint of fever in their child,
- Child admitted to the emergency observation room for treatment,
- Able to speak and understand Turkish.
Who cannot join
- Illiterate mothers,
- Mothers whose children have had febrile seizures,
- Mothers whose children have comorbid diseases,
- Mothers whose children have symptoms requiring medical intervention other than fever.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Erciyes University (ERÜ) Health Application and Research Center, Fevzi Mercan-Mustafa Eraslan Children's Hospital, Pediatric Emergency Unit
Kayseri, Talas, 38160
About this study
Official title: The Effect of Education Provided With Artificial Intelligence-Based Materials on Mothers' Fever Management and Anxiety Levels
This study aims to evaluate the effect of an artificial intelligence (AI)-based educational program on mothers' fever management practices and anxiety related to fever in children. Fever is a common symptom in pediatric patients, especially under the age of three, causing repeated health concerns for parents. Despite the prevalence of fever, parents often engage in inappropriate fever management practices, which may lead to unnecessary anxiety and improper care. The study was conducted as a pretest-posttest experimental design including 80 mothers of children who presented to the Pediatric Emergency Unit at Erciyes University, Fevzi Mercan-Mustafa Eraslan Children's Hospital. Participants were assigned to either an intervention group receiving AI-supported fever management education or a control group receiving standard care. Data were collected using validated scales to assess parental fever management practices and anxiety levels before and after the intervention. The educational material was developed using ChatGPT 4.0, a large language model AI platform, and reviewed by pediatric experts. The results of this study may improve fever management education and reduce anxiety among mothers, potentially leading to better health outcomes for children.
Read the detailed description
This study investigates the impact of an AI-supported educational program on mothers' fever management practices and anxiety. Fever is common in pediatric patients and can cause significant concern for parents, especially for children under three years old. Parents often engage in inappropriate fever management practices, leading to improper care and increased anxiety. The study uses a pretest-posttest experimental design involving 80 mothers who presented to the Pediatric Emergency Unit at Erciyes University, Fevzi Mercan-Mustafa Eraslan Children's Hospital. Participants were assigned to either an intervention group receiving education developed using ChatGPT 4.0, reviewed by pediatric experts, or a control group receiving standard care. Data collection tools include validated scales measuring fever management practices and anxiety levels. The intervention aims to improve mothers' fever management practices and reduce anxiety, potentially improving child health outcomes.
- Being tested
- AI-Based Fever Management Education
- Keywords
- Fever, Pediatric Fever, Fever Management, Parental Education, Anxiety, Artificial Intelligence
- Medical subject headings
- Fever, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AI-Based Fever Management EducationOther
Also called ChatGPT-based Educational Material
This intervention consists of a fever management education program developed using ChatGPT 4.0, a large language model by OpenAI. The educational content includes seven pages and eight visuals explaining how to manage fever in children. The content was reviewed by pediatric specialists and revised accordingly. It is delivered as a one-time structured session to mothers in the intervention group.
| Study group | Role | What they receive |
|---|---|---|
| AI-Based Education Group | Experimental | Mothers in this group will receive fever management education developed using an artificial intelligence language model (ChatGPT 4.0). The education includes written materials with visual content on managing fever in children and is delivered as a one-time structured session. Receives: Other: AI-Based Fever Management Education |
| Control Group | No intervention | Mothers in this group will receive routine care and no additional fever education materials. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Parents' Fever Management Practices
The Parents' Fever Management Scale (PFMS; Turkish: EAYÖ), developed by Walsh et al. (2008) and validated in Turkish by Altun et al. (2011), measures parents' fever management practices. It consists of 8 items rated on a 5-point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always), yielding a total score ranging from 8 to 40. Higher total scores indicate more fever phobia and less appropriate fever management practices, whereas lower scores indicate more appropriate practices. Therefore, a decrease in the total score reflects improvement. In this study, a reduction in PFMS scores in the intervention group relative to the control group was hypothesized.
Measured: Baseline and 2 weeks after intervention
Secondary outcomes (1)
Change in Parental Anxiety Levels
Anxiety was measured using the short version of the State-Trait Anxiety Inventory (STAI-S), consisting of 5 items rated on a 4-point Likert scale, with total scores ranging from 5 to 20. Higher scores indicate greater anxiety and lower scores indicate less anxiety; therefore, a decrease in the score reflects reduced anxiety.
Measured: Baseline and 2 weeks after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jul 2025
- Study start1 Oct 2025
- Primary completion20 Apr 2026
- Study completion30 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for FeverStudies of the same condition, open and under way.
- More trials run by TC Erciyes UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants (mothers of children) will be randomly assigned to one of two groups: an intervention group receiving AI-supported fever management education, and a control group receiving standard care. Outcomes will be compared between the two groups to evaluate the effect of the educational intervention.
- Masking
- None (open label)
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- TC Erciyes University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, ISMIRA JULFAYEVA, TC Erciyes University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07086547
- Sponsor's protocol ID
- 10718356
- Other IDs
- 10718356
- Acronym
- AI-FEVER
- Status last verified
- Sep 2025
- First submitted
- 18 Jul 2025
- Last updated
- 23 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: "We have not yet determined whether individual participant data will be shared. Decisions will be made after study completion."
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Education Provided With Artificial Intelligence-Based Materials on Mothers' Fever Management and Anxiety Levels
- ClinicalTrials.gov ID
- NCT07086547
- Acronym / sponsor ID
- AI-FEVER / 10718356
- Keywords
- Fever, Pediatric Fever, Fever Management, Parental Education, Anxiety, Artificial Intelligence
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- TC Erciyes UniversityUniversity, hospital or other
- Study start
- 1 Oct 2025 (actual)
- Primary completion
- 20 Apr 2026 (actual)
- Study completion
- 30 Apr 2026 (actual)
- First posted
- 25 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effect of an artificial intelligence (AI)-based educational program on mothers' fever management practices and anxiety related to fever in children. Fever is a common symptom in pediatric patients, especially under the age of three, causing repeated health concerns for parents. Despite the prevalence of fever, parents often engage in inappropriate fever management practices, which may lead to unnecessary anxiety and improper care. The study was conducted as a pretest-posttest experimental design including 80 mothers of children who presented to the Pediatric Emergency Unit at Erciyes University, Fevzi Mercan-Mustafa Eraslan Children's Hospital. Participants were assigned to either an intervention group receiving AI-supported fever management education or a control group receiving standard care. Data were collected using validated scales to assess parental fever management practices and anxiety levels before and after the intervention. The educational material was developed using ChatGPT 4.0, a large language model AI platform, and reviewed by pediatric experts. The results of this study may improve fever management education and reduce anxiety among mothers, potentially leading to better health outcomes for children.
Detailed description
This study investigates the impact of an AI-supported educational program on mothers' fever management practices and anxiety. Fever is common in pediatric patients and can cause significant concern for parents, especially for children under three years old. Parents often engage in inappropriate fever management practices, leading to improper care and increased anxiety. The study uses a pretest-posttest experimental design involving 80 mothers who presented to the Pediatric Emergency Unit at Erciyes University, Fevzi Mercan-Mustafa Eraslan Children's Hospital. Participants were assigned to either an intervention group receiving education developed using ChatGPT 4.0, reviewed by pediatric experts, or a control group receiving standard care. Data collection tools include validated scales measuring fever management practices and anxiety levels. The intervention aims to improve mothers' fever management practices and reduce anxiety, potentially improving child health outcomes.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants (mothers of children) will be randomly assigned to one of two groups: an intervention group receiving AI-supported fever management education, and a control group receiving standard care. Outcomes will be compared between the two groups to evaluate the effect of the educational intervention.
| Arm | Type | Receives |
|---|---|---|
| AI-Based Education Group | Experimental | Other: AI-Based Fever Management EducationMothers in this group will receive fever management education developed using an artificial intelligence language model (ChatGPT 4.0). The education includes written materials with visual content on managing fever in children and is delivered as a one-time structured session. |
| Control Group | No intervention | –Mothers in this group will receive routine care and no additional fever education materials. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Mothers aged over 18 years,
- Mothers with children aged between 6 months and 5 years,
- No hearing problems,
- Agree to participate in the study,
- Presenting to the pediatric emergency department with a complaint of fever in their child,
Key exclusion criteria (4 listed)
- Illiterate mothers,
- Mothers whose children have had febrile seizures,
- Mothers whose children have comorbid diseases,
- Mothers whose children have symptoms requiring medical intervention other than fever.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AI-Based Fever Management EducationAlso: ChatGPT-based Educational MaterialThis intervention consists of a fever management education program developed using ChatGPT 4.0, a large language model by OpenAI. The educational content includes seven pages and eight visuals explaining how to manage fever in children. The content was reviewed by pediatric specialists and revised accordingly. It is delivered as a one-time structured session to mothers in the intervention group. | Other | AI-Based Education Group |
Primary outcome
Change in Parents' Fever Management Practices
Time frame: Baseline and 2 weeks after intervention
The Parents' Fever Management Scale (PFMS; Turkish: EAYÖ), developed by Walsh et al. (2008) and validated in Turkish by Altun et al. (2011), measures parents' fever management practices. It consists of 8 items rated on a 5-point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always), yielding a total score ranging from 8 to 40. Higher total scores indicate more fever phobia and less appropriate fever management practices, whereas lower scores indicate more appropriate practices. Therefore, a decrease in the total score reflects improvement. In this study, a reduction in PFMS scores in the intervention group relative to the control group was hypothesized.
1 secondary outcome
Change in Parental Anxiety Levels
Time frame: Baseline and 2 weeks after intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2026.
- Individual participant dataSharing planned: Undecided. "We have not yet determined whether individual participant data will be shared. Decisions will be made after study completion."
Related trials for Fever
Recruiting
Assessment of Communication Interventions on Vaccination Knowledge and Acceptance
Vaccination Knowledge and Acceptance, Informed Vaccine-decision Making
RecruitingObservational study
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Trisomy 8 Mosaicism, Trisomy 8 Associated Autoinflammatory Disease
RecruitingObservational study
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Familial Mediterranean Fever (FMF), Autoinflammation
RecruitingPhase 1
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Peritoneal Mesothelioma, Peritoneal Carcinomatosis
Recruiting
Recovery After Fatigue in Young Athletes: Comparison Between TECAR Therapy and Cycle Ergometer"
Muscle Fatigue, Healthy Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AI-Based Fever Management Education in people with Fever and Pediatric Fever Management, run by TC Erciyes University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Parents' Fever Management Practices (time frame: Baseline and 2 weeks after intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026.